5Ratjen F, Rjabko O, Kremens B. High-dose eorticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant ,2005,36 : 135-138. 被引量：1
7Colom AJ, Teper AM, Vollmer WM, et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax, 2006,61:503-506. 被引量：1
8Teper A, Fischer GB, Jones MH. Respiratory sequelae of viral diseases : from diagnosis to treatment. J Pediatr ( Rio J), 2002, 78 : 187-194. 被引量：1
9Yalcin E, Dogru D, Haliloglu M, et al. Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors. Respiration, 2003,70:371-375. 被引量：1
10Kim CK, Kim SW, Kim JS, et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest, 2001,120: 1101- 1106. 被引量：1
6WesoIowski A, Targowski T. Community-acquired pneumonia caused by biological pathogens [ J ]. Pol Merkur Lekarski, 2012,33(197) :248-251. 被引量：1
7Johnstone J, Mandell L. Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia [ J ]. Infect Dis Clin North Am, 2013,27 ( 1 ) :71-86. 被引量：1
8da Rocha Neto O G, Leite R F, Baldi B G. Update on viral community-acquired pneumonia [J]. Rev Assoc Med Bras, 2013,59( 1 ) :78-84. 被引量：1
9Viasus D, Garcia-Vidal C, Carratala J. Advances in antibiotic therapy for community-acquired pneumonia [ J ]. Curr Opin Pulm Med, 2013,19(3) :209-215. 被引量：1
10Craig W A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men [J]. Clin Infect Dis, 1998,26 ( 1 ) : 1 - 10. 被引量：1
